Chan, J. A., Ryan, D. P., Zhu, A. X., Abrams, T. A., Wolpin, B. M., Malinowski, P., . . . Kulke, M. H. (2012). Phase I Study of Pasireotide (SOM 230) and Everolimus (RAD001) in Advanced Neuroendocrine Tumors. Endocr Relat Cancer.

Chan, Jennifer A., David P. Ryan, Andrew X. Zhu, Thomas A. Abrams, Brian M. Wolpin, Paige Malinowski, Eileen M. Regan, Charles S. Fuchs, et Matthew H. Kulke. "Phase I Study of Pasireotide (SOM 230) and Everolimus (RAD001) in Advanced Neuroendocrine Tumors." Endocr Relat Cancer 2012.

Chan, Jennifer A., et al. "Phase I Study of Pasireotide (SOM 230) and Everolimus (RAD001) in Advanced Neuroendocrine Tumors." Endocr Relat Cancer 2012.